Li Jian, Wang Wei
Department of Interventional Oncology, Municipal Hospital Affiliated to Taizhou University, Taizhou 318000, Zhejiang Province, China.
World J Hepatol. 2025 Jul 27;17(7):107213. doi: 10.4254/wjh.v17.i7.107213.
infections (KPIs), particularly carbapenem-resistant (CRKP), pose significant challenges in liver transplantation (LT) recipients, with high morbidity and mortality. Guo 's study highlights risk factors, such as elevated day-one alanine aminotransferase levels and prolonged catheterization, and identifies polymyxin B and ceftazidime/avibactam as effective treatments. However, limitations like the absence of pre-transplant colonization data and host-pathogen interaction insights highlight the need for enhanced strategies. Future directions should include routine CRKP colonization surveillance, immune and genomic profiling, and the development of novel therapeutics. By integrating these approaches, we can improve the prevention, diagnosis, and treatment of KPIs in LT patients.
感染(关键绩效指标),尤其是耐碳青霉烯类肺炎克雷伯菌(CRKP),给肝移植(LT)受者带来了重大挑战,其发病率和死亡率都很高。郭的研究强调了一些风险因素,如第一天丙氨酸转氨酶水平升高和导管插入时间延长,并确定多粘菌素B和头孢他啶/阿维巴坦为有效的治疗方法。然而,像缺乏移植前定植数据和宿主-病原体相互作用见解等局限性凸显了加强策略的必要性。未来的方向应包括常规的CRKP定植监测、免疫和基因组分析以及新型治疗方法的开发。通过整合这些方法,我们可以改善LT患者中关键绩效指标的预防、诊断和治疗。